Chronic Illness

69 articles
by Nima Toussi

Financial toxicity: The relationship between cancer and poverty

Beating cancer doesn't always mean patients will lead healthy and fulfilling lives. They also face the challenge of staying out of the poverty cycle and debt traps throughout the course of their treatment.

by Jayden Battey Peter Zhang

Prescribing community for mental health – lessons from Australia

Without the right combination of medication, housing and community, patients can receive treatment only to find themselves lonely, disconnected, homeless, incarcerated or back in hospital again. Housing communities may offer help.

by Cyndi Gilbert Michelle Cohen

Naturopathic doctors: Underutilized partners in public health and primary care

Naturopathic doctors (NDs) have an important role to play in the health-care system. We need a pilot project to assess the viability of ND integration into team-based primary care models.

by Miranda So Jennifer Curran Shahid Husain Mark McIntyre Andrew Morris Jenna Sauve Shreeya Thakrar Bohang Zhao

Turning back the tide: The challenge of antimicrobial resistance and its impact on our health

As antimicrobial stewardship clinicians, we implement system-level interventions and engage with prescribers to promote behaviour change in antimicrobial use. It's not too late to turn back the tide on antimicrobial resistance, but we must start now.

by Tania Di Renna Rachael Bosma

There is no quick fix for chronic pain but there is a path forward

Patients need to be at the centre of their own care, and they need to manage their pain for what it is, a chronic disease. The time to reimagine chronic pain care is now – we can’t afford not to and the millions of suffering Canadians can’t afford to wait.

by Sangeetha Nadarajah

Gummies for pain relief? Using cannabis while on prescription drugs risky for seniors

Despite their widespread use, you may want to think twice before giving grandma cannabis gummies for her knee pain.

by Nickrooz Grami

Do doctors know enough about the commercial determinants of health?

Private sector activities have a real impact on people's health. We need to promote healthy cross-industry regulation and scrutinize the role that private interests play in the health-policy arena to help safeguard the health of patients.

by Jennifer Beeman Jane E. McArthur

It’s not all pretty in pink: To prevent breast cancer, let’s stop missing the forest for the trees

Breast cancer rates, even among young people, are on the rise. For this Breast Cancer Awareness month, there's more we could be doing to prevent the disease before it starts.

by Mehreen Zaman

Yes, patients and caregivers are experts

Does being a patient make you an expert on your condition? Does formal education and credentials to comprehend a disease outweigh the rigor of experiencing life with the disease? There may be more room for patient-expert buy-in in health care decisions.

by Mary Sco.

Mushrooms, nuts and collard greens: Nutrition and how to lower the odds of breast cancer

Breast cancer is the product of many factors over a lifetime. While some of those factors are out of our control, others like diet offer opportunities to mitigate risk.

by Evan Watson Louis Hugo Francescutti Eddy Lang

Housing first: The case for social prescribing of housing in emergency departments

Providing permanent housing is not only something that can and has been realistically implemented for unhoused patients in emergency departments, it also has been shown to reduce ED visits and hospitalizations and produce health benefits.

by Maddi Dellplain

Should “magic mushrooms” be legalized? Experts weigh in

Psilocybin, a psychedelic compound found in "magic mushrooms", is making waves for its therapeutic benefits in treating psychiatric conditions like major depressive disorder and end-of-life anxiety. But does that mean it should be legalized? We asked a panel of experts to weigh in.

by Kaden Venugopal

Why Canada must amend the Controlled Drugs and Substances Act

MAiD is currently available for those with mental illness. But there are treatment options that exist that have yet to be legalized. It's time to increase access to psychedelic-assisted therapies.

by The Disability and Reproductive Health during COVID-19 Study Team

Access denied: Pandemic highlighted issues in accessing sexual and reproductive health for persons with disabilities

The COVID-19 pandemic led to a number of people with disabilities missing health-care appointments due largely to health and safety concerns on transit. But there are measures we can take to provide accessible, disability-affirming care.

by Ediriweera Desapriya Crystal Ma Kenneth Ong Sandhita Saha

Safeguarding our children: Vaccination’s crucial role in navigating the coming school year

As we embark on the new school year, the lessons we have learned from the ongoing COVID-19 pandemic serve as our compass, guiding us toward effective strategies while helping us discern the ones that fall short.

by Caroline Brereton

Reducing opioid use for back, neck and shoulder pain starts with interprofessional collaboration

The COVID-19 pandemic has added fuel to the opioid crisis, particularly in treating chronic back pain. But there are several ways to address musculoskeletal pain that don't require medication.

by Sandor J. Demeter

Lung-cancer screening – primum non nocere (first, do no harm)!

Lung cancer is the number one global killer among cancers. Early detection can help patients' chance of survival but current screening measures also come with mixed benefits and risks.

by Anne Borden King

Despite convictions, harmful health products like MMS bleach continue to be sold

Policymakers have begun to address health disinformation and harmful products on social media, signaling hope that it could become easier to stop operations like Genesis II. But we still need to address the desperation that drives people to reach for these products to begin with.

by Joanne Kotsopoulos Steve Narod

We have the tools to prevent ovarian cancer. Why aren’t we using them?

About 20 per cent of the ovarian cancer cases in Canada diagnosed each year are in people who carry a mutation and are most likely preventable. Genetic testing can become more accessible. Why are we waiting? 

by Christopher Leighton

If public health is not there to protect the vulnerable, then why bother?

Documents reveal that though the risks could not have been stated more clearly, in 2022 the Ford government ignored the evidence and lifted public health measures. This should worry all Ontarians.

2 of 4